Literature DB >> 23616860

Towards meaningful medication-related clinical decision support: recommendations for an initial implementation.

S Phansalkar, A Wright, G J Kuperman, A J Vaida, A M Bobb, R A Jenders, T H Payne, J Halamka, M Bloomrosen, D W Bates.   

Abstract

SUMMARY: Clinical decision support (CDS) can improve safety, quality, and cost-effectiveness of patient care, especially when implemented in computerized provider order entry (CPOE) applications. Medication-related decision support logic forms a large component of the CDS logic in any CPOE system. However, organizations wishing to implement CDS must either purchase the computable clinical content or develop it themselves. Content provided by vendors does not always meet local expectations. Most organizations lack the resources to customize the clinical content and the expertise to implement it effectively. In this paper, we describe the recommendations of a national expert panel on two basic medication-related CDS areas, specifically, drug-drug interaction (DDI) checking and duplicate therapy checking. The goals of this study were to define a starter set of medication-related alerts that healthcare organizations can implement in their clinical information systems. We also draw on the experiences of diverse institutions to highlight the realities of implementing medication decision support. These findings represent the experiences of institutions with a long history in the domain of medication decision support, and the hope is that this guidance may improve the feasibility and efficiency CDS adoption across healthcare settings.

Entities:  

Keywords:  CDS; Clinical decision support; decision support systems; drug-drug interactions; medical informatics; medication alerting; therapeutic duplication

Year:  2011        PMID: 23616860      PMCID: PMC3631914          DOI: 10.4338/ACI-2010-04-RA-0026

Source DB:  PubMed          Journal:  Appl Clin Inform        ISSN: 1869-0327            Impact factor:   2.342


  26 in total

1.  Improving acceptance of computerized prescribing alerts in ambulatory care.

Authors:  Nidhi R Shah; Andrew C Seger; Diane L Seger; Julie M Fiskio; Gilad J Kuperman; Barry Blumenfeld; Elaine G Recklet; David W Bates; Tejal K Gandhi
Journal:  J Am Med Inform Assoc       Date:  2005-10-12       Impact factor: 4.497

2.  Clinical decision support in electronic prescribing: recommendations and an action plan: report of the joint clinical decision support workgroup.

Authors:  Jonathan M Teich; Jerome A Osheroff; Eric A Pifer; Dean F Sittig; Robert A Jenders
Journal:  J Am Med Inform Assoc       Date:  2005-03-31       Impact factor: 4.497

3.  Clinical decision support and electronic prescribing systems: a time for responsible thought and action.

Authors:  Randolph A Miller; Reed M Gardner; Kevin B Johnson; George Hripcsak
Journal:  J Am Med Inform Assoc       Date:  2005-05-19       Impact factor: 4.497

4.  Customizing a commercial rule base for detecting drug-drug interactions.

Authors:  Ervina Resetar; Richard M Reichley; Laura A Noirot; Wm Claiborne Dunagan; Thomas C Bailey
Journal:  AMIA Annu Symp Proc       Date:  2005

Review 5.  Clinically significant drug-drug interactions between oral anticancer agents and nonanticancer agents: profiling and comparison of two drug compendia.

Authors:  Chen-May Wong; Yu Ko; Alexandre Chan
Journal:  Ann Pharmacother       Date:  2008-11-25       Impact factor: 3.154

6.  Turning off frequently overridden drug alerts: limited opportunities for doing it safely.

Authors:  Heleen van der Sijs; Jos Aarts; Teun van Gelder; Marc Berg; Arnold Vulto
Journal:  J Am Med Inform Assoc       Date:  2008-04-24       Impact factor: 4.497

7.  Impact of computerized physician order entry on physician time.

Authors:  D W Bates; D L Boyle; J M Teich
Journal:  Proc Annu Symp Comput Appl Med Care       Date:  1994

8.  Tiering drug-drug interaction alerts by severity increases compliance rates.

Authors:  Marilyn D Paterno; Saverio M Maviglia; Paul N Gorman; Diane L Seger; Eileen Yoshida; Andrew C Seger; David W Bates; Tejal K Gandhi
Journal:  J Am Med Inform Assoc       Date:  2008-10-24       Impact factor: 4.497

9.  Clinicians' assessments of electronic medication safety alerts in ambulatory care.

Authors:  Saul N Weingart; Brett Simchowitz; Lawrence Shiman; Daniela Brouillard; Adrienne Cyrulik; Roger B Davis; Thomas Isaac; Michael Massagli; Laurinda Morway; Daniel Z Sands; Justin Spencer; Joel S Weissman
Journal:  Arch Intern Med       Date:  2009-09-28

10.  Characteristics and consequences of drug allergy alert overrides in a computerized physician order entry system.

Authors:  Tyken C Hsieh; Gilad J Kuperman; Tonushree Jaggi; Patricia Hojnowski-Diaz; Julie Fiskio; Deborah H Williams; David W Bates; Tejal K Gandhi
Journal:  J Am Med Inform Assoc       Date:  2004-08-06       Impact factor: 4.497

View more
  10 in total

1.  High-priority drug-drug interactions for use in electronic health records.

Authors:  Shobha Phansalkar; Amrita A Desai; Douglas Bell; Eileen Yoshida; John Doole; Melissa Czochanski; Blackford Middleton; David W Bates
Journal:  J Am Med Inform Assoc       Date:  2012-04-26       Impact factor: 4.497

2.  Development and dissemination of clinical decision support across institutions: standardization and sharing of refugee health screening modules.

Authors:  Evan W Orenstein; Katherine Yun; Clara Warden; Michael J Westerhaus; Morgan G Mirth; Dean Karavite; Blain Mamo; Kavya Sundar; Jeremy J Michel
Journal:  J Am Med Inform Assoc       Date:  2019-12-01       Impact factor: 4.497

3.  Drug interaction alert override rates in the Meaningful Use era: no evidence of progress.

Authors:  A D Bryant; G S Fletcher; T H Payne
Journal:  Appl Clin Inform       Date:  2014-09-03       Impact factor: 2.342

4.  Comparison of Overridden Medication-related Clinical Decision Support in the Intensive Care Unit between a Commercial System and a Legacy System.

Authors:  Adrian Wong; Adam Wright; Diane L Seger; Mary G Amato; Julie M Fiskio; David Bates
Journal:  Appl Clin Inform       Date:  2017-08-23       Impact factor: 2.342

5.  Don't fuel the fire: decreasing intravenous haloperidol use in high risk patients via a customized electronic alert.

Authors:  Jonathan Michael Pell; Dora Cheung; Michael A Jones; Ethan Cumbler
Journal:  J Am Med Inform Assoc       Date:  2014-06-13       Impact factor: 4.497

6.  Loss of the heterogeneous expression of flippase ATP11B leads to cerebral small vessel disease in a normotensive rat model.

Authors:  Sophie Quick; Tessa V Procter; Jonathan Moss; Luise Seeker; Marc Walton; Angus Lawson; Serena Baker; Anna Beletski; Daniela Jaime Garcia; Mehreen Mohammad; William Mungall; Ami Onishi; Zuzanna Tobola; Michael Stringer; Maurits A Jansen; Antoine Vallatos; Ylenia Giarratano; Miguel O Bernabeu; Joanna M Wardlaw; Anna Williams
Journal:  Acta Neuropathol       Date:  2022-05-30       Impact factor: 15.887

7.  Exploring How to Better Measure and Improve the Quality of Medication Reconciliation.

Authors:  Joshua M Pevnick; Jeffrey L Schnipper
Journal:  Jt Comm J Qual Patient Saf       Date:  2017-03-29

8.  Comparison of three commercial knowledge bases for detection of drug-drug interactions in clinical decision support.

Authors:  Kin Wah Fung; Joan Kapusnik-Uner; Jean Cunningham; Stefanie Higby-Baker; Olivier Bodenreider
Journal:  J Am Med Inform Assoc       Date:  2017-07-01       Impact factor: 4.497

9.  Utilization and cost of electronic resources in adult cancer center.

Authors:  Fatma Maraiki; Siobhan Kelly; Mohamed Ahmed; Sakra Balhareth; Tusneem Elhasan; Mahmoud Aljurf; Shouki Bazarbashi
Journal:  BMC Res Notes       Date:  2018-07-28

10.  An e-Delphi study to obtain expert consensus on the level of risk associated with preventable e-prescribing events.

Authors:  Jude Heed; Stephanie Klein; Ann Slee; Neil Watson; Andy Husband; Sarah Patricia Slight
Journal:  Br J Clin Pharmacol       Date:  2022-03-08       Impact factor: 3.716

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.